Survey of the use of catecholamines by French physicians
- PMID: 14997293
- DOI: 10.1007/s00134-004-2172-1
Survey of the use of catecholamines by French physicians
Abstract
Objective: The objective of the study was to perform a descriptive approach of the current use of catecholamines by French physicians.
Design: A questionnaire of 12 questions with 4 items established by a group of French intensivists.
Population: French physicians from 433 departments working in the following practicing areas: intensive care unit (ICU), emergency department, and pre-hospital setting.
Measurements: Responding physicians were asked about the catecholamine that they would select in various clinical settings.
Results: The response rate was 82%. Of the responding physicians, 277 (78%) worked in an ICU, 28 (8%) in an emergency department, and 21 (6%) in a pre-hospital setting. Dobutamine was chosen for patients with cardiogenic shock by 90% of the respondents. Norepinephrine was the first choice agent as vasopressor in patients with septic shock in 52% of the cases. Dopamine was selected in a clinical setting requiring an optimization of regional blood flow, as in the concept of high-risk surgical patients. Dopexamine was used as a second or third choice agent to improve regional blood flow and cardiac output. The indications of epinephrine for anaphylactic shock and cardio-circulatory arrest were obvious for more than 90% of responding physicians.
Conclusion: A lack of standardization appears in the use of catecholamines by French physicians, particularly for improvement of regional circulation and management of high-risk surgical patients. Guidelines that define the place of each catecholamine in these settings are required to improve the quality of prescription.
Similar articles
-
Extensive variability in vasoactive agent therapy: a nationwide survey in Chinese intensive care units.Chin Med J (Engl). 2015 Apr 20;128(8):1014-20. doi: 10.4103/0366-6999.155064. Chin Med J (Engl). 2015. PMID: 25881592 Free PMC article.
-
[Use of catecholamines for shock. A continuous debate!].Tunis Med. 2012 Apr;90(4):291-9. Tunis Med. 2012. PMID: 22535343 French.
-
Does change of catecholamine use improve the outcome of patients with shock admitted to intensive care unit?Am J Ther. 2014 Sep-Oct;21(5):358-65. doi: 10.1097/MJT.0b013e318251f0eb. Am J Ther. 2014. PMID: 23584311
-
Use of catecholamines in acute myocardial infarction.Herz. 1979 Oct;4(5):385-96. Herz. 1979. PMID: 391685 Review.
-
Catecholamines and splanchnic perfusion.Schweiz Med Wochenschr. 2000 Dec 16;130(50):1942-7. Schweiz Med Wochenschr. 2000. PMID: 11189440 Review.
Cited by
-
Vasopressors for hypotensive shock.Cochrane Database Syst Rev. 2016 Feb 15;2(2):CD003709. doi: 10.1002/14651858.CD003709.pub4. Cochrane Database Syst Rev. 2016. PMID: 26878401 Free PMC article.
-
Pharmacologic agents for acute hemodynamic instability: recent advances in the management of perioperative shock- a systematic review.Ann Card Anaesth. 2015 Oct-Dec;18(4):543-54. doi: 10.4103/0971-9784.166464. Ann Card Anaesth. 2015. PMID: 26440241 Free PMC article.
-
Vasoactive-inotropic agents in pediatric patients undergoing cardiac surgery: A single-center retrospective study.Medicine (Baltimore). 2025 May 2;104(18):e42333. doi: 10.1097/MD.0000000000042333. Medicine (Baltimore). 2025. PMID: 40324232 Free PMC article.
-
Improvement in process of care and outcome in patients requiring intensive care unit admission for community acquired pneumonia.BMC Infect Dis. 2013 Apr 30;13:196. doi: 10.1186/1471-2334-13-196. BMC Infect Dis. 2013. PMID: 23631630 Free PMC article.
-
Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.Cochrane Database Syst Rev. 2018 Jan 29;1(1):CD009669. doi: 10.1002/14651858.CD009669.pub3. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2020 Nov 5;11:CD009669. doi: 10.1002/14651858.CD009669.pub4. PMID: 29376560 Free PMC article. Updated.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources